Alkermes Plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alkermes Plc with three other
pharmaceutical manufacturers in Europe:
Virbac
of FRANCE
(2019
sales of 938.34 million Euros [US$1.05 billion]
of which 59%
was Companion Animals),
Almirall SA
of SPAIN
(855.34 million Euros [US$955.69 million]
of which 63%
was Own Network (Spain)), and
Orion Oyj
which is
based in FINLAND
(1.05 billion Euros [US$1.17 billion]
of which 100%
was Pharmaceuticals Business).

Sales Analysis.
Alkermes Plc reported sales of 1.05 billion Euro (US$1.17 billion)
for the
year ending
December of 2019.
This
represents
an
increase of 12.8%
versus 2018, when the company's sales were 928.72 million Euro.
Sales at Alkermes Plc have increased during each of the previous five years
(and since 2014, sales have increased a total of 124%).